| 8.75 BATS BZX Real-Time Price As of 10:34am ET |  +0.26 / +3.06%Today’s Change | 3.90 Today|||52-Week Range 12.53 | +76.41% Year-to-Date |
| Previous close | 8.49 |
| Today’s open | 8.60 |
| Day’s range | 8.59 - 8.76 |
| Volume | 3,755,981 |
| Average volume (3 months) | 28,106,555 |
| Market cap | $8.8B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +219.06% |
| P/E ratio | NM |
| Price/Sales | 76.68 |
| Price/Book | 4.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRONCronos Group Inc | +0.79 | +5.36% |
| ARGXargenx SE | +3.80 | +2.99% |
| USNAUSANA Health Science... | +0.89 | +1.17% |
| APHAAphria Inc | +0.39 | +5.88% |
| Next reporting date | September 24, 2019 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $43.5M |
| Annual profit (last year) | $56.6M |
| Net profit margin | 130.33% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Terry Booth |
President & Director Steve Dobler |
Corporate headquarters Edmonton, Alberta |
